HUMA logo

HUMA Humacyte, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$0.45
-0.10 (-17.90%)

Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomical locations and therapeutic fields. The company employs its distinct scientific and proprietary technology platform to produce human acellular vessels…

Market Cap: $123.73Mwww.humacyte.com

Price

No data yet.

Social Signal Score

45
5d
30
1 mentions
—
30d
46
11 mentions
—
60d
53
19 mentions
—
90d
51
22 mentions
—
news: 22

Analyst Ratings

11 analysts
Buyconsensus
Strong Buy 0Buy 9Hold 2Sell 0Strong Sell 0
Avg price target$1.33+198.6%
Low $1Median $1High $2
Current Consensus

Revenue

$1.03M+303.14%
$0.00$2.41M$4.82M$7.23M
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-0.29
$-0.30–$-0.27
3 analysts
FY2026
$-0.36
$-0.38–$-0.34
3 analysts
FY2027
$-0.24
$-0.26–$-0.21
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Laura E. Niklason
Sector
Healthcare
Industry
Biotechnology
Employees
184
Beta
2.68
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-9.86
www.humacyte.com